A detailed history of Envestnet Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 81,078 shares of REGN stock, worth $56.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
81,078
Previous 75,452 7.46%
Holding current value
$56.9 Million
Previous $79.3 Million 7.48%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1024.09 - $1201.76 $5.76 Million - $6.76 Million
5,626 Added 7.46%
81,078 $85.2 Million
Q2 2024

Aug 08, 2024

BUY
$883.2 - $1071.19 $7.25 Million - $8.79 Million
8,209 Added 12.21%
75,452 $79.3 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $3.39 Million - $3.73 Million
3,760 Added 5.92%
67,243 $64.7 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $4.49 Million - $5.11 Million
5,794 Added 10.04%
63,483 $55.8 Million
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $3.55 Million - $4.33 Million
-5,133 Reduced 8.17%
57,689 $47.5 Million
Q2 2023

Aug 04, 2023

SELL
$700.03 - $830.35 $1.3 Billion - $1.54 Billion
-1,853,952 Reduced 96.72%
62,822 $45.1 Million
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $1.26 Billion - $1.53 Billion
1,848,784 Added 2719.2%
1,916,774 $1.57 Billion
Q4 2022

Feb 07, 2023

SELL
$705.89 - $766.39 $7.17 Million - $7.78 Million
-10,152 Reduced 12.99%
67,990 $49.1 Million
Q3 2022

Nov 10, 2022

BUY
$573.97 - $724.32 $1.96 Million - $2.47 Million
3,415 Added 4.57%
78,142 $53.8 Million
Q2 2022

Aug 03, 2022

SELL
$548.35 - $738.84 $2.74 Million - $3.7 Million
-5,003 Reduced 6.27%
74,727 $44.2 Million
Q1 2022

May 04, 2022

SELL
$595.12 - $698.43 $5.17 Million - $6.07 Million
-8,693 Reduced 9.83%
79,730 $55.7 Million
Q4 2021

Feb 04, 2022

BUY
$543.48 - $670.97 $11.3 Million - $13.9 Million
20,763 Added 30.69%
88,423 $55.8 Million
Q3 2021

Oct 07, 2021

BUY
$574.03 - $680.96 $1.67 Million - $1.98 Million
2,908 Added 4.49%
67,660 $40.9 Million
Q2 2021

Aug 04, 2021

SELL
$472.8 - $558.54 $4,728 - $5,585
-10 Reduced 0.02%
64,752 $36.2 Million
Q1 2021

May 04, 2021

BUY
$446.73 - $548.2 $1.49 Million - $1.83 Million
3,335 Added 5.43%
64,762 $30.6 Million
Q4 2020

Feb 02, 2021

SELL
$478.3 - $607.98 $268,326 - $341,076
-561 Reduced 0.91%
61,427 $29.7 Million
Q3 2020

Oct 09, 2020

SELL
$544.75 - $658.21 $123,658 - $149,413
-227 Reduced 0.36%
61,988 $34.7 Million
Q2 2020

Jul 08, 2020

BUY
$493.32 - $643.92 $3.1 Million - $4.04 Million
6,278 Added 11.22%
62,215 $38.8 Million
Q1 2020

Apr 23, 2020

BUY
$336.18 - $494.43 $3.8 Million - $5.59 Million
11,309 Added 25.34%
55,937 $27.3 Million
Q4 2019

Feb 11, 2020

SELL
$274.13 - $376.51 $121,165 - $166,417
-442 Reduced 0.98%
44,628 $16.8 Million
Q3 2019

Oct 17, 2019

SELL
$273.46 - $318.39 $206,735 - $240,702
-756 Reduced 1.65%
45,070 $12.5 Million
Q2 2019

Aug 02, 2019

SELL
$299.6 - $414.82 $1.11 Million - $1.54 Million
-3,701 Reduced 7.47%
45,826 $14.3 Million
Q1 2019

May 10, 2019

SELL
$372.08 - $439.57 $2.3 Million - $2.72 Million
-6,188 Reduced 11.11%
49,527 $20.3 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $18.3 Million - $22 Million
54,624 Added 5006.78%
55,715 $20.8 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $4.99 Million - $5.81 Million
-14,216 Reduced 92.87%
1,091 $441,000
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $80,826 - $97,977
-284 Reduced 1.82%
15,307 $5.28 Million
Q1 2018

May 09, 2018

SELL
$315.82 - $393.78 $2.29 Million - $2.86 Million
-7,264 Reduced 31.78%
15,591 $5.32 Million
Q4 2017

Feb 20, 2018

SELL
$358.63 - $469.95 $199,398 - $261,292
-556 Reduced 2.37%
22,855 $8.59 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $40,981 - $47,880
95 Added 0.41%
23,411 $10.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
23,316
23,316 $11.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.